Acorah Software Products - Accounts Production 19.1.200 false true false true No description of principal activity 30 August 2024 31 December 2025 31 December 2025 15926621 Ms Y Zhao iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15926621 2024-08-29 15926621 2025-12-31 15926621 2024-08-30 2025-12-31 15926621 frs-core:CurrentFinancialInstruments 2025-12-31 15926621 frs-bus:PrivateLimitedCompanyLtd 2024-08-30 2025-12-31 15926621 frs-bus:FilletedAccounts 2024-08-30 2025-12-31 15926621 frs-bus:Micro-entities 2024-08-30 2025-12-31 15926621 frs-bus:AuditExempt-NoAccountantsReport 2024-08-30 2025-12-31 15926621 frs-bus:Director1 2024-08-30 2025-12-31
Registered number: 15926621
Sirio (UK) Healthcare Co., Ltd.
Unaudited Financial Statements
For the Period 30 August 2024 to 31 December 2025
Overpaidtax Limited
Balance Sheet
Registered number: 15926621
31 December 2025
£
Current assets 148,632
Prepayments and accrued income 20,729
Creditors: Amounts Falling Due Within One Year (178,695 )
NET CURRENT LIABILITIES (9,334 )
TOTAL ASSETS LESS CURRENT LIABILITIES (9,334 )
NET LIABILITIES (9,334 )
CAPITAL AND RESERVES (9,334 )

Notes

1. General Information
Sirio (UK) Healthcare Co., Ltd. is a private company, limited by shares, incorporated in England & Wales, registered number 15926621 . The registered office is Suite 1, 7th Floor 50 Broadway, London, SW1H 0DB.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 2
2
For the period ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Ms Y Zhao
Director
27/04/2026